_id
6921efd9b93c8af7a393360b
Ticker
LSBCF
Name
LakeShore Biopharma Co., Ltd
Exchange
NYSE
Address
Building No. 2, Beijing, China, 102629
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.lakeshorebio.com
Description
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.
Last Close
0.845
Volume
1
Current Price
0.845
Change
0.005
Last Updated
2026-01-05T09:53:32.333Z
Image
-
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-06-30
Revenue
135527333
Cost Of Revenue
101119004
Gross Profit
34408329
Operating Expenses
215553846
Operating Income
-181145517
Interest Expense
23635947
Pretax Income
-194896565
Net Income
-181410236
Eps
-1.8142717948429203
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-13719098
EBITDA
-82617124
Operating Margin
-133.6597666243458
Total Other Income Expense Net
-13751048
Cash
246351231
Short Term Investments
-
Receivables
444161291
Inventories
205085341
Total Current Assets
903167952
Property Plant Equipment
480623373
Total Assets
1513027356
Payables
67774798
Short Term Debt
323697272
Long Term Debt
-
Total Liabilities
927821054
Equity
585206302
Bs_currency_symbol
-
Depreciation
10546346
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
0.14438003872521524
ROE
-30.99936473343037
ROA
-11.989884735435014
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
31
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
1.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
135527333
Quarters > 0 > income Statement > cost Of Revenue
101119004
Quarters > 0 > income Statement > gross Profit
34408329
Quarters > 0 > income Statement > operating Expenses
215553846
Quarters > 0 > income Statement > operating Income
-181145517
Quarters > 0 > income Statement > interest Expense
23635947
Quarters > 0 > income Statement > pretax Income
-194896565
Quarters > 0 > income Statement > net Income
-181410236
Quarters > 0 > income Statement > eps
-1.8142717948429203
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
99990661
Quarters > 0 > income Statement > income Tax Expense
-13719098
Quarters > 0 > income Statement > EBITDA
-82617124
Quarters > 0 > income Statement > operating Margin
-133.6597666243458
Quarters > 0 > income Statement > total Other Income Expense Net
-13751048
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
246351231
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
444161291
Quarters > 0 > balance Sheet > inventories
205085341
Quarters > 0 > balance Sheet > total Current Assets
903167952
Quarters > 0 > balance Sheet > property Plant Equipment
480623373
Quarters > 0 > balance Sheet > total Assets
1513027356
Quarters > 0 > balance Sheet > payables
67774798
Quarters > 0 > balance Sheet > short Term Debt
323697272
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
927821054
Quarters > 0 > balance Sheet > equity
585206302
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-181410236
Quarters > 0 > cash Flow > depreciation
10546346
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.8142717948429203
Quarters > 0 > ratios > PB
0.14438003872521524
Quarters > 0 > ratios > ROE
-30.99936473343037
Quarters > 0 > ratios > ROA
-11.989884735435014
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2023-12-31
Quarters > 1 > income Statement > revenue
168705602
Quarters > 1 > income Statement > cost Of Revenue
34898919
Quarters > 1 > income Statement > gross Profit
133806682
Quarters > 1 > income Statement > operating Expenses
217964062
Quarters > 1 > income Statement > operating Income
-81428370
Quarters > 1 > income Statement > interest Expense
8352814
Quarters > 1 > income Statement > pretax Income
-84953762
Quarters > 1 > income Statement > net Income
-77770202
Quarters > 1 > income Statement > eps
-0.8357157348841907
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
93058200
Quarters > 1 > income Statement > income Tax Expense
-7189156
Quarters > 1 > income Statement > EBITDA
-72354211
Quarters > 1 > income Statement > operating Margin
-48.2665477818573
Quarters > 1 > income Statement > total Other Income Expense Net
-3525392
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
222659449
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
403122000
Quarters > 1 > balance Sheet > inventories
190781127
Quarters > 1 > balance Sheet > total Current Assets
826767808
Quarters > 1 > balance Sheet > property Plant Equipment
568831000
Quarters > 1 > balance Sheet > total Assets
1510727820
Quarters > 1 > balance Sheet > payables
10924652
Quarters > 1 > balance Sheet > short Term Debt
428982000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1035921000
Quarters > 1 > balance Sheet > equity
474604442
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-77619773
Quarters > 1 > cash Flow > depreciation
9154207
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
-0.8357157348841907
Quarters > 1 > ratios > PB
0.16568361363967174
Quarters > 1 > ratios > ROE
-16.386319873508473
Quarters > 1 > ratios > ROA
-5.147863233232839
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2023-09-30
Quarters > 2 > income Statement > revenue
96818454
Quarters > 2 > income Statement > cost Of Revenue
17507142
Quarters > 2 > income Statement > gross Profit
79311312
Quarters > 2 > income Statement > operating Expenses
179362368
Quarters > 2 > income Statement > operating Income
-113204615
Quarters > 2 > income Statement > interest Expense
6898098
Quarters > 2 > income Statement > pretax Income
-105215151
Quarters > 2 > income Statement > net Income
-104980798
Quarters > 2 > income Statement > eps
-1.1281198366652214
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
93058197
Quarters > 2 > income Statement > income Tax Expense
-234353
Quarters > 2 > income Statement > EBITDA
-98475361
Quarters > 2 > income Statement > operating Margin
-116.92462575368121
Quarters > 2 > income Statement > total Other Income Expense Net
7989464
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
259905532
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
429368934
Quarters > 2 > balance Sheet > inventories
212820371
Quarters > 2 > balance Sheet > total Current Assets
934605218
Quarters > 2 > balance Sheet > property Plant Equipment
571285599
Quarters > 2 > balance Sheet > total Assets
1611283104
Quarters > 2 > balance Sheet > payables
11639246
Quarters > 2 > balance Sheet > short Term Debt
30057361
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1054186774
Quarters > 2 > balance Sheet > equity
557096330
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-105017700
Quarters > 2 > cash Flow > depreciation
14729254
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
CNY
Quarters > 2 > ratios > PE
-1.1281198366652214
Quarters > 2 > ratios > PB
0.14115005292711227
Quarters > 2 > ratios > ROE
-18.84428102407352
Quarters > 2 > ratios > ROA
-6.515353989586674
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
176274000
Quarters > 3 > income Statement > cost Of Revenue
34680000
Quarters > 3 > income Statement > gross Profit
141594000
Quarters > 3 > income Statement > operating Expenses
210174000
Quarters > 3 > income Statement > operating Income
-70054000
Quarters > 3 > income Statement > interest Expense
8028000
Quarters > 3 > income Statement > pretax Income
-70128000
Quarters > 3 > income Statement > net Income
-69542000
Quarters > 3 > income Statement > eps
-0.747295802432106
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
93058197
Quarters > 3 > income Statement > income Tax Expense
-586000
Quarters > 3 > income Statement > EBITDA
-60839000
Quarters > 3 > income Statement > operating Margin
-39.74153874082395
Quarters > 3 > income Statement > total Other Income Expense Net
-74000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
94749000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
495907000
Quarters > 3 > balance Sheet > inventories
182370000
Quarters > 3 > balance Sheet > total Current Assets
1006175000
Quarters > 3 > balance Sheet > property Plant Equipment
577806000
Quarters > 3 > balance Sheet > total Assets
1689876000
Quarters > 3 > balance Sheet > payables
10180685
Quarters > 3 > balance Sheet > short Term Debt
28686474
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1029123000
Quarters > 3 > balance Sheet > equity
660753000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-69418515
Quarters > 3 > cash Flow > depreciation
1261000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.747295802432106
Quarters > 3 > ratios > PB
0.11900691554181365
Quarters > 3 > ratios > ROE
-10.524658987549055
Quarters > 3 > ratios > ROA
-4.115213187239774
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
614961584
Annuals > 0 > income Statement > cost Of Revenue
107772147
Annuals > 0 > income Statement > gross Profit
507189437
Annuals > 0 > income Statement > operating Expenses
593481321
Annuals > 0 > income Statement > operating Income
-86291884
Annuals > 0 > income Statement > interest Expense
15739410
Annuals > 0 > income Statement > pretax Income
-100929324
Annuals > 0 > income Statement > net Income
-99982451
Annuals > 0 > income Statement > eps
-0.935087285751788
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
106923121
Annuals > 0 > income Statement > income Tax Expense
-946873
Annuals > 0 > income Statement > EBITDA
-48538306
Annuals > 0 > income Statement > operating Margin
-14.032077164677007
Annuals > 0 > income Statement > total Other Income Expense Net
-14637440
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
28083556
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
501790254
Annuals > 0 > balance Sheet > inventories
227591892
Annuals > 0 > balance Sheet > total Current Assets
842218000
Annuals > 0 > balance Sheet > property Plant Equipment
414348776
Annuals > 0 > balance Sheet > total Assets
1367663211
Annuals > 0 > balance Sheet > payables
49551779
Annuals > 0 > balance Sheet > short Term Debt
390897107
Annuals > 0 > balance Sheet > long Term Debt
23503471
Annuals > 0 > balance Sheet > total Liabilities
867908580
Annuals > 0 > balance Sheet > equity
499754631
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-99982451
Annuals > 0 > cash Flow > depreciation
36651608
Annuals > 0 > cash Flow > change In Working Capital
-115380797
Annuals > 0 > cash Flow > cash From Operations
-120981727
Annuals > 0 > cash Flow > capital Expenditures
17858614
Annuals > 0 > cash Flow > cash From Investing
-17006500
Annuals > 0 > cash Flow > cash From Financing
-3580946
Annuals > 0 > cash Flow > net Change In Cash
-139066265
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-0.935087285751788
Annuals > 0 > ratios > PB
0.18078879442139678
Annuals > 0 > ratios > ROE
-20.006308055602588
Annuals > 0 > ratios > ROA
-7.310458466371659
Annuals > 0 > ratios > FCF
-138840341
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.22577075481189732
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
573418256
Annuals > 1 > income Statement > cost Of Revenue
117688301
Annuals > 1 > income Statement > gross Profit
455729955
Annuals > 1 > income Statement > operating Expenses
901562457
Annuals > 1 > income Statement > operating Income
-445832502
Annuals > 1 > income Statement > interest Expense
44344808
Annuals > 1 > income Statement > pretax Income
-455193478
Annuals > 1 > income Statement > net Income
-433464871
Annuals > 1 > income Statement > eps
-4.053986330982613
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
106923121
Annuals > 1 > income Statement > income Tax Expense
-21728607
Annuals > 1 > income Statement > EBITDA
-368663287
Annuals > 1 > income Statement > operating Margin
-77.7499665096118
Annuals > 1 > income Statement > total Other Income Expense Net
-9360976
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
246351231
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
444161291
Annuals > 1 > balance Sheet > inventories
203422602
Annuals > 1 > balance Sheet > total Current Assets
903167952
Annuals > 1 > balance Sheet > property Plant Equipment
480623373
Annuals > 1 > balance Sheet > total Assets
1513027356
Annuals > 1 > balance Sheet > payables
67774798
Annuals > 1 > balance Sheet > short Term Debt
323697272
Annuals > 1 > balance Sheet > long Term Debt
98983780
Annuals > 1 > balance Sheet > total Liabilities
927821054
Annuals > 1 > balance Sheet > equity
585206302
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-433464871
Annuals > 1 > cash Flow > depreciation
42185383
Annuals > 1 > cash Flow > change In Working Capital
-45789326
Annuals > 1 > cash Flow > cash From Operations
-295229603
Annuals > 1 > cash Flow > capital Expenditures
44250714
Annuals > 1 > cash Flow > cash From Investing
-44250714
Annuals > 1 > cash Flow > cash From Financing
205261352
Annuals > 1 > cash Flow > net Change In Cash
-123818594
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-4.053986330982613
Annuals > 1 > ratios > PB
0.15439006199389835
Annuals > 1 > ratios > ROE
-74.07043798376594
Annuals > 1 > ratios > ROA
-28.648845592980805
Annuals > 1 > ratios > FCF
-339480317
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.5920291400697922
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
687201070
Annuals > 2 > income Statement > cost Of Revenue
153360262
Annuals > 2 > income Statement > gross Profit
533840808
Annuals > 2 > income Statement > operating Expenses
673223159
Annuals > 2 > income Statement > operating Income
-139382351
Annuals > 2 > income Statement > interest Expense
30857673
Annuals > 2 > income Statement > pretax Income
-282337298
Annuals > 2 > income Statement > net Income
-145479105
Annuals > 2 > income Statement > eps
-1.879044983074025
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
77421832
Annuals > 2 > income Statement > income Tax Expense
1133504
Annuals > 2 > income Statement > EBITDA
-76800121
Annuals > 2 > income Statement > operating Margin
-20.282615537836694
Annuals > 2 > income Statement > total Other Income Expense Net
-142954947
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
370108059
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
468202865
Annuals > 2 > balance Sheet > inventories
185380952
Annuals > 2 > balance Sheet > total Current Assets
1035978664
Annuals > 2 > balance Sheet > property Plant Equipment
582888871
Annuals > 2 > balance Sheet > total Assets
1719753611
Annuals > 2 > balance Sheet > payables
80439489
Annuals > 2 > balance Sheet > short Term Debt
198490110
Annuals > 2 > balance Sheet > long Term Debt
293790596
Annuals > 2 > balance Sheet > total Liabilities
991300326
Annuals > 2 > balance Sheet > equity
728453285
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
-145479105
Annuals > 2 > cash Flow > depreciation
36687807
Annuals > 2 > cash Flow > change In Working Capital
-92746222
Annuals > 2 > cash Flow > cash From Operations
-182469396
Annuals > 2 > cash Flow > capital Expenditures
57049721
Annuals > 2 > cash Flow > cash From Investing
-56981720
Annuals > 2 > cash Flow > cash From Financing
317449926
Annuals > 2 > cash Flow > net Change In Cash
99302322
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
-1.879044983074025
Annuals > 2 > ratios > PB
0.0898087075549395
Annuals > 2 > ratios > ROE
-19.970958741712586
Annuals > 2 > ratios > ROA
-8.459299289705053
Annuals > 2 > ratios > FCF
-239519117
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.3485429919368432
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
502949894
Annuals > 3 > income Statement > cost Of Revenue
121459719
Annuals > 3 > income Statement > gross Profit
381490175
Annuals > 3 > income Statement > operating Expenses
500448838
Annuals > 3 > income Statement > operating Income
-118958663
Annuals > 3 > income Statement > interest Expense
2717433
Annuals > 3 > income Statement > pretax Income
-231729605
Annuals > 3 > income Statement > net Income
-236666727
Annuals > 3 > income Statement > eps
-8.022600915254237
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
29500000
Annuals > 3 > income Statement > income Tax Expense
4937122
Annuals > 3 > income Statement > EBITDA
-67195877
Annuals > 3 > income Statement > operating Margin
-23.652189695063342
Annuals > 3 > income Statement > total Other Income Expense Net
-112770942
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
271067503
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
308555105
Annuals > 3 > balance Sheet > inventories
166505565
Annuals > 3 > balance Sheet > total Current Assets
764764393
Annuals > 3 > balance Sheet > property Plant Equipment
565003393
Annuals > 3 > balance Sheet > total Assets
201034150
Annuals > 3 > balance Sheet > payables
30811100
Annuals > 3 > balance Sheet > short Term Debt
116056006
Annuals > 3 > balance Sheet > long Term Debt
253928000
Annuals > 3 > balance Sheet > total Liabilities
20352000
Annuals > 3 > balance Sheet > equity
671252204
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
-106004401
Annuals > 3 > cash Flow > depreciation
31153969
Annuals > 3 > cash Flow > change In Working Capital
-138707848
Annuals > 3 > cash Flow > cash From Operations
-173545357
Annuals > 3 > cash Flow > capital Expenditures
298931958
Annuals > 3 > cash Flow > cash From Investing
-298923958
Annuals > 3 > cash Flow > cash From Financing
364558145
Annuals > 3 > cash Flow > net Change In Cash
-119389581
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
-8.022600915254237
Annuals > 3 > ratios > PB
0.03713581847695505
Annuals > 3 > ratios > ROE
-35.25749719549524
Annuals > 3 > ratios > ROA
-117.72463882380183
Annuals > 3 > ratios > FCF
-472477315
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.9394122966054348
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.8142717948429203
Valuation > metrics > PB
0.14438003872521524
Valuation > final Score
70
Valuation > verdict
85.6% Undervalued
Profitability > metrics > ROE
-30.99936473343037
Profitability > metrics > ROA
-20.085991270868302
Profitability > metrics > Net Margin
-1.3385509179908381
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.5854597785927467
Risk > metrics > Interest Coverage
-7.663983888608313
Risk > final Score
-1
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.3071069974417333
Liquidity > metrics > Quick Ratio
1.7832245631214507
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-21
Prev Risks > 1
-36
Prev Risks > 2
-5
Prev Liquidities > 0
97
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:12:03.293Z
Earnings History > 0 > period
2024-06-30
Earnings History > 0 > report Date
2024-08-15
Earnings History > 0 > date
2024-06-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-13.4
Earnings History > 0 > eps Estimate
-5.8
Earnings History > 0 > eps Difference
-7.6
Earnings History > 0 > surprise Percent
-131.0345
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-04-19
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-8.3
Earnings History > 1 > eps Estimate
-4.2
Earnings History > 1 > eps Difference
-4.1
Earnings History > 1 > surprise Percent
-97.619
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2024-01-22
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-11.28
Earnings History > 2 > eps Estimate
-6.2
Earnings History > 2 > eps Difference
-5.08
Earnings History > 2 > surprise Percent
-81.9355
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALakeShore Biopharma Sets February 12 EGM to Approve Going-Private Merger TipRanks
Read more →Nasdaq Delisting: LakeShore Biopharma Shifts to OTC Market Due to Minimum Price Requirements Stock Titan
Read more →(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of LakeShore Biopharma Co., Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-06-30
EPS Actual
-13.4
EPS Estimate
-5.8
EPS Difference
-7.6
Surprise Percent
-131.0345%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.